2012
DOI: 10.1364/boe.3.000966
|View full text |Cite
|
Sign up to set email alerts
|

Tissue phantoms in multicenter clinical trials for diffuse optical technologies

Abstract: Tissue simulating phantoms are an important part of instrumentation validation, standardization/training and clinical translation. Properly used, phantoms form the backbone of sound quality control procedures. We describe the development and testing of a series of optically turbid phantoms used in a multi-center American College of Radiology Imaging Network (ACRIN) clinical trial of Diffuse Optical Spectroscopic Imaging (DOSI). The ACRIN trial is designed to measure the response of breast tumors to neoadjuvant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
59
0
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(63 citation statements)
references
References 13 publications
(15 reference statements)
1
59
0
3
Order By: Relevance
“…Such optical measurement systems for biomedical applications rely on tissue-equivalent phantoms for testing system design and comparing di®erent measurement methods. [2][3][4][5][6][7][8][9] Use of real human tissues is impractical since the optical properties of such samples change in various atmospheric conditions (i.e., humidity, temperature) and rapidly degrade over time, thus they are unusable as standards with known and stable properties. Therefore, optical properties of phantoms (scattering coe±cient s , absorption coe±cient a , scattering anisotropy factor g, refractive index n, and thickness L) should be properly tuned to correspond to that of tissues they mimic.…”
Section: Introductionmentioning
confidence: 99%
“…Such optical measurement systems for biomedical applications rely on tissue-equivalent phantoms for testing system design and comparing di®erent measurement methods. [2][3][4][5][6][7][8][9] Use of real human tissues is impractical since the optical properties of such samples change in various atmospheric conditions (i.e., humidity, temperature) and rapidly degrade over time, thus they are unusable as standards with known and stable properties. Therefore, optical properties of phantoms (scattering coe±cient s , absorption coe±cient a , scattering anisotropy factor g, refractive index n, and thickness L) should be properly tuned to correspond to that of tissues they mimic.…”
Section: Introductionmentioning
confidence: 99%
“…The refractive index of phantom is lower than the real value at 500 nm [22]. Nevertheless, this is not disturbing, when μ a and μ s approach the values of the ex-vivo tissue [23]. Summarizing from the previous results, we have successfully fabricated the object phantom with 4 seperate rows of vessels and a transparent phantom to ensure the feasibility of including liquid into the hollow vessels.…”
Section: Optical Properties Compared With Ex-vivo Skin Tissuementioning
confidence: 79%
“…To determine the change in optical properties required to match the measured and simulated data, simulations were repeated using a range of optical properties. Full agreement was achieved when the background absorption was 2 × greater than the absorption of the anomaly, significantly higher than the measured contrast (∼1:1) and beyond any measurement error in the optical properties of the silicone phantom [36,39]. The limited mesh resolution (2 mm node-to-node distance) may also contribute to the discrepancy; the large volume required to model the experimental set-up limited the resolution.…”
Section: Comparison Of Experimental and Simulated Datamentioning
confidence: 86%
“…The absorption spectrum, μ a (λ), of India ink was measured in a spectrophotometer and added to the intrinsic absorption of the silicone and Intralipid ® [35]. The reduced scattering spectrum, ( ) s µ λ ′ , of the solid phantom was measured using an established frequencydomain diffuse reflectance technique [36,37], while the reduced scattering coefficients of various dilutions of the 20% Intralipid ® stock solution at 690 nm were measured using an in-house CW-DOT system that will be the basis for the first clinical prototype and will be described in a future publication. The values at each of the three wavelengths were then calculated using the following equation, which is based on Mie scattering theory [38]:…”
Section: Tissue-simulating Phantomsmentioning
confidence: 99%